These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 15752257)

  • 21. Differential regulation of p63 and p73 expression.
    Waltermann A; Kartasheva NN; Dobbelstein M
    Oncogene; 2003 Aug; 22(36):5686-93. PubMed ID: 12944917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between vascular endothelial growth factor (VEGF) expression and tumor angiogenesis in ameloblastomas.
    Kumamoto H; Ohki K; Ooya K
    J Oral Pathol Med; 2002 Jan; 31(1):28-34. PubMed ID: 11896820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical analysis of inducible nitric oxide synthase (iNOS) and heat shock proteins (HSPs) in ameloblastomas.
    Kumamoto H; Suzuki T; Ooya K
    J Oral Pathol Med; 2002 Nov; 31(10):605-11. PubMed ID: 12406306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of parathyroid hormone-related protein (PTHrP), osteoclast differentiation factor (ODF)/receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoclastogenesis inhibitory factor (OCIF)/osteoprotegerin (OPG) in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2004 Jan; 33(1):46-52. PubMed ID: 14675140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer.
    Tannapfel A; Schmelzer S; Benicke M; Klimpfinger M; Kohlhaw K; Mössner J; Engeland K; Wittekind C
    J Pathol; 2001 Sep; 195(2):163-70. PubMed ID: 11592094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of p53, p63 and p73 proteins in human buccal squamous-cell carcinomas.
    Chen YK; Huse SS; Lin LM
    Clin Otolaryngol Allied Sci; 2003 Oct; 28(5):451-5. PubMed ID: 12969350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions.
    Nylander K; Coates PJ; Hall PA
    Int J Cancer; 2000 Aug; 87(3):368-72. PubMed ID: 10897041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of p63 and p73 expression in benign and malignant salivary gland lesions.
    Seethala RR; LiVolsi VA; Zhang PJ; Pasha TL; Baloch ZW
    Head Neck; 2005 Aug; 27(8):696-702. PubMed ID: 16021638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivo.
    Perez-Losada J; Wu D; DelRosario R; Balmain A; Mao JH
    Oncogene; 2005 Aug; 24(35):5521-4. PubMed ID: 16007185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of p53, p63 and p73 in the orofacial region of human embryos.
    Cernochová D; Pospísilová E; Kylarová D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2004 Dec; 148(2):203-4. PubMed ID: 15744376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?
    Faridoni-Laurens L; Bosq J; Janot F; Vayssade M; Le Bihan ML; Kaghad M; Caput D; Bénard J; Ahomadegbe JC
    Oncogene; 2001 Aug; 20(38):5302-12. PubMed ID: 11536043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TP53 family members and human cancers.
    Bénard J; Douc-Rasy S; Ahomadegbe JC
    Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical detection of retinoblastoma protein and E2 promoter-binding factor-1 in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2006 Mar; 35(3):183-9. PubMed ID: 16454815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low expression of p63 and p73 in osteosarcoma.
    Park HR; Kim YW; Park JH; Maeng YH; Nojima T; Hashimoto H; Park YK
    Tumori; 2004; 90(2):239-43. PubMed ID: 15237589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
    Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
    J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence.
    Papadogianni D; Soulitzis N; Delakas D; Spandidos DA
    Tumour Biol; 2014 Mar; 35(3):2481-9. PubMed ID: 24213852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical detection of platelet-derived endothelial cell growth factor/thymidine phosphorylase and angiopoietins in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2006 Nov; 35(10):606-12. PubMed ID: 17032393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.
    Flores ER; Sengupta S; Miller JB; Newman JJ; Bronson R; Crowley D; Yang A; McKeon F; Jacks T
    Cancer Cell; 2005 Apr; 7(4):363-73. PubMed ID: 15837625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p63 and p73 are not required for the development and p53-dependent apoptosis of T cells.
    Senoo M; Manis JP; Alt FW; McKeon F
    Cancer Cell; 2004 Jul; 6(1):85-9. PubMed ID: 15261144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.